Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Plos One
|
April 14, 2021
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
Atul T Patel, Mark F Lew, Khashayar Dashtipour, et al.
Plos One
|
February 1, 2021
Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
Atul T Patel, Mark F Lew, Khashayar Dashtipour, et al.
Neurology
|
January 31, 2024
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
June 28, 2016
OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process
David M Simpson, Atul T Patel, Abraham Alfaro, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
September 28, 2016
Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post-Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm
Alberto Esquenazi, Khashayar Dashtipour, Abraham Alfaro, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 23, 2025
Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE study
Grace Forde, Kimberly Becker Ifantides, Angeli Mayadev, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
March 14, 2017
OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a Delphi Panel Approach
Alberto Esquenazi, Abraham Alfaro, Ziyad Ayyoub, et al.
Toxins
|
January 22, 2024
Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis
Franco Molteni, Jörg Wissel, Klemens Fheodoroff, et al.
Clinical Parkinsonism & Related Disorders
|
December 10, 2021
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
Mark F Lew, Robert A Hauser, Stuart H Isaacson, et al.
Movement Disorders Clinical Practice
|
February 4, 2026
DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real-World Early Experience Program
Laxman Bahroo, Aaron Ellenbogen, Robert A Hauser, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Plos One
|
April 14, 2021
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
Atul T Patel, Mark F Lew, Khashayar Dashtipour, et al.
Plos One
|
February 1, 2021
Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
Atul T Patel, Mark F Lew, Khashayar Dashtipour, et al.
Neurology
|
January 31, 2024
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
June 28, 2016
OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process
David M Simpson, Atul T Patel, Abraham Alfaro, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
September 28, 2016
Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post-Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm
Alberto Esquenazi, Khashayar Dashtipour, Abraham Alfaro, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 23, 2025
Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE study
Grace Forde, Kimberly Becker Ifantides, Angeli Mayadev, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
March 14, 2017
OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a Delphi Panel Approach
Alberto Esquenazi, Abraham Alfaro, Ziyad Ayyoub, et al.
Toxins
|
January 22, 2024
Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis
Franco Molteni, Jörg Wissel, Klemens Fheodoroff, et al.
Clinical Parkinsonism & Related Disorders
|
December 10, 2021
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
Mark F Lew, Robert A Hauser, Stuart H Isaacson, et al.
Movement Disorders Clinical Practice
|
February 4, 2026
DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real-World Early Experience Program
Laxman Bahroo, Aaron Ellenbogen, Robert A Hauser, et al.
Page
of 4